Previous 10 | Next 10 |
PRINCETON, N.J., July 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2022. Second Quarter 2022 Highlights Second q...
Morgan Stanley research initiated medical device company Integra LifeSciences ( NASDAQ: IART ) on Monday with an equal-weight rating and a price target of $59, implying an 8.6% upside for the stock. IART shares +1.4% to $55.10 in mid-day trading. Princeton, N.J.-base...
PRINCETON, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Renee Lo to its board of directors as an independent director to fill an existing vacancy, effecti...
PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- ) Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2022 financial results on Wednesday, July 27, 2022, prior to the market open. In conjunction w...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
HILCO REDEVELOPMENT PARTNERS ANNOUNCES INTEGRA TO OCCUPY NEW BRAINTREE FACILITY PR Newswire BRAINTREE, Mass. , May 11, 2022 /PRNewswire/ -- Hilco Redevelopment Partners (HRP) announced that Integra LifeSciences, NASDAQ: IART ( https://www.integralife.co...
Integra LifeSciences Holdings Corporation (IART) Q1 2022 Earnings Conference Call April 27, 2022, 8:30 AM ET Company Participants Jan De Witte – President & Chief Executive Officer Glenn Coleman – Chief Operating Officer Carrie Anderson – Chief Financial Officer Chris...
The following slide deck was published by Integra LifeSciences Holdings Corporation in conjunction with their 2022 Q1 earnings call. For further details see: Integra LifeSciences Holdings Corporation 2022 Q1 - Results - Earnings Call Presentation
Integra LifeSciences Holdings press release (NASDAQ:IART): Q1 Non-GAAP EPS of $0.74 beats by $0.06. Revenue of $376.6M (+4.6% Y/Y) beats by $14.41M. Adjusted EBITDA for the first quarter of 2022 was $93.5 million, or 24.8% of revenue, compared to $89.9 million, or 25.0% of revenue, in the pri...
PRINCETON, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2022. First Quarter 2022 Highlights Revenues...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
21.25%Change Percent:
Integra LifeSciences Holdings Corporation Company Name:
IART Stock Symbol:
NASDAQ Market:
Integra LifeSciences Holdings Corporation Website:
2024-07-29 18:00:04 ET Ryan Zimmerman from BTIG issued a price target of $22.00 for IART on 2024-07-29 16:12:00. The adjusted price target was set to $22.00. At the time of the announcement, IART was trading at $25.42. The overall price target consensus is at $51.17 with...
2024-07-29 17:15:01 ET BTIG analyst issues SELL recommendation for IART on July 29, 2024 04:12PM ET. IART was trading at $25.42 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy, 2 - Hold, 1 - Sell ...
2024-07-29 12:23:00 ET Shares of Integra Lifesciences (NASDAQ: IART) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the market opened. Integra reported Q2 revenue of $418.2 million,...